An update: Cancer-associated anorexia as a treatment target

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Loss of appetite is pervasive among patients with advanced cancer. Cancer patients cite it as one of their most troubling symptoms. To date, however, palliative options remain limited. Megestrol acetate and dexamethasone provide only modest relief. Novel agents such as thalidomide, adenosine triphosphate, and other cytokine inhibitors merit further investigation.

Original languageEnglish (US)
Pages (from-to)179-182
Number of pages4
JournalCurrent Opinion in Clinical Nutrition and Metabolic Care
Volume4
Issue number3
DOIs
StatePublished - May 2001

Fingerprint

Anorexia
anorexia
megestrol
Megestrol Acetate
neoplasms
Thalidomide
adenosine triphosphate
Appetite
dexamethasone
Dexamethasone
signs and symptoms (animals and humans)
Neoplasms
cytokines
Adenosine Triphosphate
acetates
Cytokines
Therapeutics

ASJC Scopus subject areas

  • Food Science
  • Endocrinology
  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism

Cite this

@article{82e4803dad33407dbd83aaedf91ba208,
title = "An update: Cancer-associated anorexia as a treatment target",
abstract = "Loss of appetite is pervasive among patients with advanced cancer. Cancer patients cite it as one of their most troubling symptoms. To date, however, palliative options remain limited. Megestrol acetate and dexamethasone provide only modest relief. Novel agents such as thalidomide, adenosine triphosphate, and other cytokine inhibitors merit further investigation.",
author = "Aminah Jatoi and Loprinzi, {Charles Lawrence}",
year = "2001",
month = "5",
doi = "10.1097/00075197-200105000-00002",
language = "English (US)",
volume = "4",
pages = "179--182",
journal = "Current Opinion in Clinical Nutrition and Metabolic Care",
issn = "1363-1950",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - An update

T2 - Cancer-associated anorexia as a treatment target

AU - Jatoi, Aminah

AU - Loprinzi, Charles Lawrence

PY - 2001/5

Y1 - 2001/5

N2 - Loss of appetite is pervasive among patients with advanced cancer. Cancer patients cite it as one of their most troubling symptoms. To date, however, palliative options remain limited. Megestrol acetate and dexamethasone provide only modest relief. Novel agents such as thalidomide, adenosine triphosphate, and other cytokine inhibitors merit further investigation.

AB - Loss of appetite is pervasive among patients with advanced cancer. Cancer patients cite it as one of their most troubling symptoms. To date, however, palliative options remain limited. Megestrol acetate and dexamethasone provide only modest relief. Novel agents such as thalidomide, adenosine triphosphate, and other cytokine inhibitors merit further investigation.

UR - http://www.scopus.com/inward/record.url?scp=0035351249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035351249&partnerID=8YFLogxK

U2 - 10.1097/00075197-200105000-00002

DO - 10.1097/00075197-200105000-00002

M3 - Article

C2 - 11517349

AN - SCOPUS:0035351249

VL - 4

SP - 179

EP - 182

JO - Current Opinion in Clinical Nutrition and Metabolic Care

JF - Current Opinion in Clinical Nutrition and Metabolic Care

SN - 1363-1950

IS - 3

ER -